A world without hepatitis C

Health Serv J. 2014 May 9;124(6397):21-3.
No abstract available

MeSH terms

  • Antiviral Agents / economics
  • Antiviral Agents / standards
  • Antiviral Agents / therapeutic use*
  • Cost-Benefit Analysis
  • Disease Eradication / economics
  • Disease Eradication / methods*
  • End Stage Liver Disease / economics
  • End Stage Liver Disease / etiology
  • End Stage Liver Disease / mortality
  • End Stage Liver Disease / prevention & control
  • England / epidemiology
  • Hepacivirus / drug effects*
  • Hepacivirus / immunology
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / economics
  • Hepatitis C, Chronic / mortality
  • Hepatitis C, Chronic / prevention & control*
  • Humans
  • Liver Neoplasms / economics
  • Liver Neoplasms / etiology
  • Liver Neoplasms / mortality
  • Liver Neoplasms / prevention & control
  • Scotland / epidemiology
  • State Medicine

Substances

  • Antiviral Agents